Dr Richard Greville is Director of ABPI Cymru Wales and Director of ABPI Northern Ireland. He was appointed to the former post in May 2003 after serving an apprenticeship of 15 years within the pharmaceutical industry. Since then he has enjoyed the challenges of raising the understanding and profile of the pharmaceutical industry with a variety of stakeholders, including professional bodies, Welsh Assembly Members and the NHS in Wales. In 2007, Richard added the role of Director of ABPI Northern Ireland to his responsibilities. He is also a member of the Advisory Boards of the Wales Office for Research and Development in Health and Social Care (WORD), Health Informatics Research Unit (HIRU) at Swansea University, Diabetes Diploma at the University of Glamorgan, and the Wales Cancer Bank.

The real value of medicines

Wales is lagging behind England in the introduction of new and innovative medicines, but could more investment in the latest treatments help solve the NHS’s financial problems?

Evolution or extinction: which way for Wales?

Continuing our science theme this week, it’s time for closer collaboration between the NHS and the pharmaceutical sector to improve research and development in Wales

Life sciences can breathe life into the Welsh economy

Research commercialisation in Wales is an area where significant progress has been made, but much more could be done to build on existing expertise in the life sciences